)
Profound Medical (PROF) investor relations material
Profound Medical Stifel 2025 Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business performance and growth
Achieved 85% revenue growth in Q3, with TULSA installed base expanding to 67 sites and targeting 75 by year-end.
Reimbursement codes implemented in January, with hospitals gradually adopting and seeing positive economic impact.
Pipeline in advanced sales stages is in the high double digits, with major institutions like Johns Hopkins, Mount Sinai, and MD Anderson starting programs.
Short-term goal is to reach 200 sites, which would generate an estimated $55M in recurring revenue and $10M in service annually, with margins over 70%.
Confident in meeting or exceeding 2026 revenue projections of $32–36M, supported by strong pipeline and increasing site utilization.
Technology and clinical innovation
TULSA PRO system offers incision-free, MR-guided prostate ablation with AI-driven treatment planning, enabling whole gland, near-whole gland, and focal treatments.
AI modules have reduced planning time by at least 20 minutes, with most procedures now managed by a single physician.
Clinical data shows significant improvements in patient recovery time and quality of life compared to standard treatments.
BPH software is set for full launch within four weeks, expanding the addressable market and allowing treatment of a broader patient population.
Kapton trial completed treatment phase; first clinical outcome data expected by next summer, with perioperative results already showing strong advantages.
Market adoption and strategy
TULSA is positioned as the only ablative option for both whole gland and focal prostate treatments, with flexibility to treat a wide range of cases.
Reimbursement and clinical data are driving adoption at both major academic centers and local hospitals.
Partnerships with Siemens and Cook support the vision of interventional MR operating suites as the next wave in surgical care.
Sonalleve, the second product, is commercial outside the US and used for women's health and oncology, with plans to evolve toward a recurring revenue model.
Brand ambassador and revamped patient outreach initiatives are increasing awareness and engagement.
Next Profound Medical earnings date
Next Profound Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)